• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.26% Nasdaq Down 0.34%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    9.68 Up 0.01(0.10%) Jul 6, 4:00PM EDT
    Add to Portfolio
    Prev Close:9.67
    Open:9.55
    Bid:9.24 x 1000
    Ask:9.88 x 2000
    1y Target Est:21.60
    Beta:6.65
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:9.53 - 9.87
    52wk Range:8.84 - 18.48
    Volume:779,139
    Avg Vol (3m):1,678,850
    Market Cap:1.00B
    P/E (ttm):N/A
    EPS (ttm):-1.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KERX

    Comparison

    Symbol% ChgMkt Cap
    KERXUp 0.10%1.00B
    BAXDown 0.68%20.68B
    SHPGDown 0.52%48.07B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):500.89
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.90
    Quarterly EPS Est (Jun-15) :-0.26
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback